Epidemiological features of malignant mesothelioma in the Republic of Belarus
https://doi.org/10.29235/1814-6023-2021-18-3-315-326
Abstract
Based on the data of the Belarusian Cancer Register for 2000–2019 the dynamics and structure of incidence of mesothelioma in the Republic of Belarus are studied. We calculated incidence rates, age-standardized incidence rates, taking into account the gender and place of residence of patients, cumulative risk. The analysis of the structure was carried out both for the whole population and separately for men and women, as well as for the urban and rural population.
We detected that the incidence rates of malignant mesothelioma in the Republic of Belarus are significantly lower than those in the Western Europe region and the Central and Eastern European region. For the period from 2000 to 2019 the dynamics of the incidence rates of mesothelioma in the Republic is characterized by a moderate tendency to decrease, and in the general structure of the incidence rate both among men and among women, pleural mesothelioma is the dominant localization. The population of regions where asbestos-cement manufacturing is located has no higher risk of developing malignant mesothelioma in comparison with population levels.
The estimated incidence of mesothelioma in men is 2 times higher than the incidence of women, and this excess is independent of age differences between these two populations. The highest incidence rates for men are observed at the age of 75–79 years, while the peak incidence for men living in the city falls at the earlier age – 70–74 years. Among women living both in the city and in rural areas, the peak incidence falls at the age of 80–84 years.
About the Authors
K. A. HutsichBelarus
Katsiaryna A. Hutsich – Head of the Laboratory
8, Akademicheskaya Str., 220012, Minsk
L. F. Levin
Belarus
Leonid F. Levin – Leading Software Engineer, Head of the Cancer Registry Department
223040, Lesnoy, Minsk region
References
1. WHO report on cancer: setting priorities, investing wisely and providing care for all. Geneva, World Health Organization, 2020, 159 p.
2. Furuya S., Chimed-Ochir O., Takahashi K., David A., Takala J. Global asbestos disaster. International Journal of Environmental Research and Public Health, 2018, vol. 15, no. 5, art. 1000. https://doi.org/10.3390/ijerph15051000
3. Attanoos R. L., Сhurg A., Galateau-Salle F., Gibbs A. R., Roggli V. L. Malignant mesothelioma and its non-asbestos causes. Archives of Pathology and Laboratory Medicine, 2018, vol. 142, no. 6, pp. 753–760. https://doi.org/10.5858/arpa.2017-0365-ra
4. Kashanskii S. V. Mesothelioma in Russia: systematic review of 3576 published cases from occupational medicine viewpoint. Meditsina truda i promyshlennaya ekologiya [Medicine of labor and industrial ecology], 2008, no. 3, pp. 15–21 (in Russian).
5. Varyvonchyk D. V. Epidemiology of malignant mesothelioma in Ukraine (2001–2011). Ukraїns’kii zhurnal z problem meditsini pratsі [Ukrainian journal about the labor medicine], 2012, no. 4, pp. 56–69 (in Russian).
6. Kundiev Yu. I., Varivonchik D. V. Occupational cancer: malignant mesothelioma. Kiev, Avіtsena Publ., 2015. 192 p. (in Russian).
7. Gualtieri A. F. (ed.). Mineral fibres: crystal chemistry, chemical-physical properties, biological interaction and toxicity. London, European Mineralogical Union, 2017. 536 p.
8. Garabrant D. H., Pastula S. T. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicology and Applied Pharmacology, 2018, vol. 361, pp. 127–136. https://doi.org/10.1016/j.taap.2018.07.003
9. Consonni D., Calvi C., De Matteis S., Mirabelli D., Landi M. T., Caporaso N. E. [et al.]. Peritoneal mesothelioma and asbestos exposure: a population-based case-control study in Lombardy, Italy. Occupational and Environmental Medicine, 2019, vol. 76, no. 8, pp. 545–553. https://doi.org/10.1136/oemed-2019-105826
10. Carbone M., Kanodia S., Chao A., Miller A., Wali A., Weissman D. [et al.]. Consensus Report of the 2015 Weinman International conference on mesothelioma. Journal of Thoracic Oncology, 2016, vol. 11, no. 8, pp. 1246–1262. https://doi.org/10.1016/j.jtho.2016.04.028
11. Noonan C. W. Environmental asbestos exposure and risk of mesothelioma. Annals of Translational Medicine, 2017, vol. 5, no. 11, art. 234. https://doi.org/10.21037/atm.2017.03.74
12. Gilham C., Rake C., Burdett G., Nicholson A.G., Davison L., Franchini A. [et al.]. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occupational and Environmental Medicine, 2016, vol. 73, no. 5, pp. 290–299. https://doi.org/10.1136/oemed-2015-103074
13. Kharazmi E., Chen T., Fallah M., Sundquist K., Sundquist J., Sundquist J., Albin M., Weiderpass E., Hemminki K. Familial risk of pleural mesothelioma increased drastically in certain occupations: a nationwide prospective cohort study. European Journal of Cancer, 2018, vol. 103, pp. 1–6. https://doi.org/10.1016/j.ejca.2018.07.139
14. Plato N., Martinsen J. I., Sparén P., Hillerdal G., Weiderpass E. Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban. Epidemiology and Health, 2016, vol. 38, art. ID e2016039. https://doi.org/10.4178/epih.e2016039
15. Asbestos Fibers and Other Elongate Mineral Particles: State of the Science and Roadmap for Research. Cincinnati, Department of health and human services Centers for Disease Control and Prevention National Institute for Occupational Safety and Health, 2011. 152 p.
16. Kovalevskii E. V. Monitoring occupational exposure to asbestos as a basis for managing the risk of developing occupational diseases. Abstract of Ph. D. diss. Moscow, 2004. 48 р. (in Russian).
17. Ibraev S. A., Otarov E. Zh., Zharylkasyn Zh. Zh., Koigel’dinova Sh. S. Controlled use of chrysotile in the development of professional risk. Meditsina Kyrgyzstana = Medicine of Kyrgyzstan, 2014, no. 4, pp. 88–90 (in Russian).
18. Cancer Today (powered by GLOBOCAN 2018). Cancer Base, no. 15. Available at: https://gco.iarc.fr/today/home (accessed 17.12.2020).
19. Prevention of occupational diseases. Geneva, International Labour Organization, 2013. 10 p.
20. Bray F. et al., ed. Cancer Incidence in Five Continents, Vol. XI. Lyon: International Agency for Research on Cancer, 2017. Available at: https://ci5.iarc.fr/CI5-XI/Default.aspx (accessed 17.12.2020).
21. Okeanov A. E., Moiseev A .A., Evmenenko A. A., Levin L. F. 25 years against cancer. Successes and problems of anti-cancer fight in Belarus in 1990-2014. Minsk, Republican Scientific Medical Library, 2016. 415 p. (in Russian).
22. dos Santos Silva I. Cancer Epidemiology: Principles and Methods. Lyon, International Agency for Research on Cancer 1999. 441 р.
23. Merabishvili V. M. Oncological statistics (traditional methods, new information technologies). Guidelines for physicians. 2nd ed. Pt. I. St. Petersburg, KOSTA Publ., 2015. 223 p. (in Russian).
24. Veyalkin I. V., Zubets O. I., Averkina T. Yu., Chakhovskii P. A. Assessment of the risk of developing environmentally and professionally caused malignant neoplasms: instructions for use. Minsk, Republican Scientific and Practical Center of Oncology and Medical Radiology named after N. N. Alexandrov, 2012. 15 p. (in Russian).
Review
For citations:
Hutsich K.A., Levin L.F. Epidemiological features of malignant mesothelioma in the Republic of Belarus. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2021;18(3):315-326. (In Russ.) https://doi.org/10.29235/1814-6023-2021-18-3-315-326